Plasma matrix metalloproteinase-3 predicts mortality in acute respiratory distress syndrome: a biomarker analysis of a randomized controlled trial

Plasma matrix metalloproteinase-3 predicts mortality in acute respiratory distress syndrome: a biomarker analysis of a randomized controlled trial

Abstract Background Matrix metalloproteinase-3 (MMP-3) is a proteolytic enzyme involved in acute respiratory distress syndrome (ARDS) pathophysiology that may serve as a lung-specific biomarker in ARDS. Methods This study was a secondary biomarker analysis of a subset of Albuterol for the Treatment...

Full description

Bibliographic Details
Main Authors: Timothy W. Jones, Sultan Almuntashiri, Aaron Chase, Abdullah Alhumaid, Payaningal R. Somanath, Andrea Sikora, Duo Zhang
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Respiratory Research
Subjects:
Acute respiratory distress syndrome
Acute lung injury
Biomarker
Matrix metalloproteinase-3
Mortality prediction
Online Access:https://doi.org/10.1186/s12931-023-02476-5

Internet

https://doi.org/10.1186/s12931-023-02476-5

Similar Items